0001683168-23-009152.txt : 20231229
0001683168-23-009152.hdr.sgml : 20231229
20231229172422
ACCESSION NUMBER: 0001683168-23-009152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DVONCH JEROME J
CENTRAL INDEX KEY: 0001518735
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33216
FILM NUMBER: 231528671
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001367083
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 680423298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 800-759-9305
MAIL ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc.
DATE OF NAME CHANGE: 20060622
4
1
ownership.xml
X0508
4
2023-12-29
0
0001367083
Sonoma Pharmaceuticals, Inc.
SNOA
0001518735
DVONCH JEROME J
C/O SONOMA PHARMACEUTICALS, INC.
5445 CONESTOGA COURT, SUITE 150
BOULDER
CO
80301
0
1
0
0
Interim CFO
0
Stock option (right to buy)
0.18
2023-12-29
4
A
0
60000
A
2033-12-29
Common Stock
60000
117777
D
The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control.
The options were awarded and granted to Mr. Dvonch for services performed as part of the Company's annual grant of stock options.
/s/ Jerome Dvonch
2023-12-29